Device Trial Radar · NCT07761598
The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY.
Last checked: Nov 20, 2026Latest source record: Aug 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
15
Planned (sponsor's estimate)
Start
Aug 2026
Primary completion
Dec 2028
Study completion Dec 2028
Sponsor
- Lead sponsor
- Jacobs instituteAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University at Buffalo
- First posted
- Aug 12, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) is a prospective, single-arm investigation.
Conditions
- Aneurysm Cerebral
Interventions
Fred X Medical Device Intervention for Aneurysm Treatment with DAPT Therapy.Device
medial device intervention for aneurysm cerebral.
Primary outcomes
What the sponsor says the trial is designed to measure.
- A thromboembolic event in the territory supplied by the treated artery.Time frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Jacobs Institute
Buffalo, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.